CSU’s contributions to developing solutions to the COVID-19 pandemic have earned it a spot on a ranking of the top 10 universities engaged in this important research, according to the website successfulstudent.org.
The team has licensed their viral RNA-testing platform to Quara Devices, a startup company specializing in diagnostic biosensors.
The research team used existing technologies to treat nine plasma and three whole-blood products.
Over the last two months, a team at CSU tested samples from 462 healthcare workers in Colorado.
Over the last decade, there have been advances in manufacturing and in strategies to rapidly produce a vaccine.
Propelled by the COVID-19 pandemic, a CSU research team is pursuing a vaccine that would thwart the novel coronavirus using a genetically modified form of the well-known probiotic Lactobacillus acidophilus, a bacterium commonly ingested in yogurt and other foods for gut health.
Given the difficulty older individuals have in controlling viral infection, the best option is for these individuals to avoid becoming infected by viruses in the first place.
CSU researchers and community members will talk about innovative women who have served as an inspiration in their lives.
Kirty Krieger says she decided to major in microbiology in the same way Harry Potter decided to become a wizard: “The major chose me.”